Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: meijer  drugs  prescription  health  healthcare  expired  unused  pharmacy  pills  safety  multivu  8497051  drugs  cost  medication  medical  health  money  prices  saving  multivu  8478051  drugs  kids  helpline  drug  free  phone  hotline  call  spanish  help  multivu  8253451  autonomous  annalee  newitz  futuristic  scifi  fantasy  torforge  book  trailer  health  medical  device  3d  fda  gore  procedure  stroke  heart  multivu  8301551  health  heart  abbott  fda  valve  doctors  healthcare  children  multivu  8280551  overdose  health  drug  addiction  opioid  crisis  faces  epidemic  multivu  8207151  cancer  health  research  treatment  disease  2017  aacr  fda  multivu  8155051  childhood  cancer  tumor  health  research  hospital  st  jude  medical  overview  multivu  8121952  opioid  overdoses  drugs  aac  help  awareness  addiction  recovery  multivu  8130951  technology  health  hearing  cochlear  nucleus  fda  app  lose  multivu  7987851  sanofi  vaccines  health  treatment  fluzone  flu  fda  medical  healthcare  multivu  8081151 
Search // drug
Results 1-12 of 136 for ' drug ' (1 seconds)
Meijer announced today it is launching its new Consumer Drug Take-Back Program by installing secure in-store kiosks designed to help customers safely and properly dispose of unused or expired prescription drugs at no cost. Customers can find the easily identifiable kiosks in the pharmacy area in all 241 Meijer supercenters across the Midwest. “Meijer is thrilled to be one of the first in our industry to provide a secure and convenient prescription drug take-back program at all stores in the communities we serve,” said Jason Beauch, Vice President of Meijer Pharmacy. “The Meijer Drug Take-Back Program allows our customers to remove the risk of an unforeseen accident occurring with expired or unused medications, while enabling them to properly dispose prescription drugs and reducing the possibility of creating a public health hazard.” To view the multimedia release go to: https://www.multivu.com/players/English/8497051-meijer-consumer-drug-take-back-program/
Categories // Miscellaneous 
Added: 147 days ago by MultiVuVideos
Runtime: 0m50s | Views: 1 | Comments: 0
Not yet rated
 

 

 

Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S. Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose. To view the multimedia release go to: https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Categories // Miscellaneous 
Added: 160 days ago by MultiVuVideos
Runtime: 1m5s | Views: 3 | Comments: 0
Not yet rated
 

 

 

Partnership for Drug-Free Kids, the nation’s leading nonprofit committed to helping families struggling with their son’s or daughter’s substance use, today announced that it has extended the hours of its free Parent Helpline. The bilingual Helpline is staffed by Parent Support Specialists, trained and caring Master’s-level counselors, who are ready to listen, help parents find answers and make an action plan for their child. Parent Support Specialists offer parents and caregivers the support and resources needed to care for a loved one who is struggling with substances. Families can connect with the Helpline via the website, drugfree.org, by phone at 855-DRUGFREE, through text messaging and Facebook Messenger. Help is available in English and Spanish. To view the multimedia release go to: https://www.multivu.com/players/English/8253451-partnership-for-drug-free-kids-extends-parent-helpline-hours/
Tags // drugs  kids  helpline  drug  free  phone  hotline  call  spanish  help  multivu  8253451 
Categories // Miscellaneous 
Added: 209 days ago by MultiVuVideos
Runtime: 2m41s | Views: 3 | Comments: 1
Not yet rated
 

 

 

Earth, 2144. Jack is an anti-patent scientist turned drug pirate, traversing the world in a submarine as a pharmaceutical Robin Hood, fabricating cheap scrips for poor people who can’t otherwise afford them. But her latest drug hack has left a trail of lethal overdoses as people become addicted to their work, doing repetitive tasks until they become unsafe or insane. Find out more at- https://us.macmillan.com/books/9780765392077 Fantasy/scifi
Categories // Miscellaneous 
Added: 468 days ago by cosproductions
Runtime: 1m3s | Views: 4 | Comments: 3
Not yet rated
 

 

 

Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.* To view the multimedia release go to: https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Categories // Miscellaneous 
Added: 469 days ago by MultiVuVideos
Runtime: 1m8s | Views: 4 | Comments: 5
Not yet rated
 

 

 

Abbott today announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world’s smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. Until today, surgeons could only use a range of larger-sized valves to replace a pediatric heart valve that could not be repaired, and larger valves are often not suitable given the smaller size of children’s hearts. This dime-sized new valve is the first and only pediatric mechanical heart valve developed for newborns and infants, and offers hope for pediatric patients in urgent need of treatment who have no other approved options. To view the multimedia release go to: https://www.multivu.com/players/English/8280551-abbott-pediatric-heart-valve-fda-approval/
Categories // Miscellaneous 
Added: 496 days ago by MultiVuVideos
Runtime: 0m47s | Views: 5 | Comments: 4
Not yet rated
 

 

 

According to a National Safety Council poll released today, one in four Americans personally knows someone who has overdosed or died from an opioid overdose, knows someone who has become addicted to opioids, or has become addicted themselves. In response to the survey results – and a recommendation from the President’s Commission for Combating Drug Addiction and the Opioid Crisis – the National Safety Council is launching a provocative nationwide public education campaign that literally puts a face on the opioid epidemic. Stericycle is the Council’s exclusive disposal partner on the campaign. To view the multimedia release go to: https://www.multivu.com/players/English/8207151-national-safety-council-stop-everyday-killers-opioids/
Categories // Miscellaneous 
Added: 614 days ago by MultiVuVideos
Runtime: 2m56s | Views: 5 | Comments: 2
Not yet rated
 

 

 

Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Categories // Miscellaneous 
Added: 671 days ago by MultiVuVideos
Runtime: 1m0s | Views: 7 | Comments: 3
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 684 days ago by MultiVuVideos
Runtime: 1m34s | Views: 3 | Comments: 0
Not yet rated
 

 

 

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces today its latest innovation, the Cochlear™ Nucleus® 7 Sound Processor. Approved by the U.S. Food and Drug Administration (FDA) in June, the Nucleus 7 Sound Processor is the world’s first Made for iPhone cochlear implant sound processor and the smallest and lightest behind-the-ear cochlear implant sound processor available on the market.1-3 With the Nucleus 7 Sound Processor, people with a Cochlear Nucleus Implant can now stream sound directly from a compatible iPhone, iPad and iPod touch directly to their sound processor.4,5* They will also be able to control, monitor and customize their hearing on their iPhone or iPod touch through the Nucleus® Smart App available to download for free from the App Store®. To view the multimedia release go to: https://www.multivu.com/players/English/7987851-cochlear-nucleus-7-sound-processor/
Categories // Miscellaneous 
Added: 720 days ago by MultiVuVideos
Runtime: 0m45s | Views: 6 | Comments: 1
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns. “As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.” To view the multimedia release go to: https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Categories // Miscellaneous 
Added: 728 days ago by MultiVuVideos
Runtime: 1m27s | Views: 7 | Comments: 1
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 754 days ago by MultiVuVideos
Runtime: 4m28s | Views: 8 | Comments: 1
Not yet rated
 

 

 

Page 1 of 12  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2019 ClipMoon.com. All rights reserved.